MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Interest Expenses came in at $3.9 million in Q4 2025, up 43.35% YoY from $2.7 million in Q4 2024, and up 27.96% on a QoQ basis from $3.1 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Interest Expenses data on file, last reported at $3.9 million in Q4 2025.
- Quarterly Interest Expenses rose 43.35% year-over-year to $3.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 1.27% YoY) and the FY2025 annual result came in at $174.8 million, up 17.02% from the prior year.
- Interest Expenses rose to $3.9 million in Q4 2025, from $3.1 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $8.6 million in Q1 2025 to a low of $119000.0 in Q4 2021.
- A 5-year average of $2.7 million and a median of $3.0 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses plunged 93.21% — and 2022, when it surged 1026.05%.
- Tracing MGTX's Interest Expenses over 5 years: stood at $119000.0 in 2021, then surged by 1026.05% to $1.3 million in 2022, then jumped by 143.13% to $3.3 million in 2023, then retreated by 16.02% to $2.7 million in 2024, then surged by 43.35% to $3.9 million in 2025.
- The last three Interest Expenses figures came in at $3.9 million (Q4 2025), $3.1 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Dec 31, 2025 | 3.06 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 3.06 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 51,000.00 |